skip to main content
Idioma:
Refinado por: Base de dados/Biblioteca: Academic OneFile remover assunto: Tumors remover Biological And Medical Sciences remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment
Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment

KANDA, J ; KAYNAR, L ; GASPARETTO, C ; CHUTE, J. P ; MORRIS, A ; WINKEL, S ; MCPHERSON, J ; KURTZBERG, J ; CHAO, N. J ; HORWITZ, M. E ; KANDA, Y ; PRASAD, V. K ; PARIKH, S. H ; LAN, L ; SHEN, T ; RIZZIERI, D. A ; LONG, G. D ; SULLIVAN, K. M

Bone marrow transplantation (Basingstoke), 2013-07, Vol.48 (7), p.926-931 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
2
Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centers
Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centers
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centers

STERN, M ; PASSWEG, J. R ; TICHELLI, A ; SCHWABE, D ; KOEHL, U ; MEYER-MONARD, S ; ESSER, R ; TONN, T ; SOERENSEN, J ; PAULUSSEN, M ; GRATWOHL, A ; KLINGEBIEL, T ; BADER, P

Bone marrow transplantation (Basingstoke), 2013-03, Vol.48 (3), p.433-438 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
3
Perspectives on inhibiting mTOR as a future treatment strategy for hematological malignancies
Perspectives on inhibiting mTOR as a future treatment strategy for hematological malignancies
Material Type:
Artigo 		Adicionar ao Meu Espaço

Perspectives on inhibiting mTOR as a future treatment strategy for hematological malignancies

CHAPUIS, N ; TAMBURINI, J ; GREEN, A. S ; WILLEMS, L ; BARDET, V ; PARK, S ; LACOMBE, C ; MAYEUX, P ; BOUSCARY, D

Leukemia, 2010-10, Vol.24 (10), p.1686-1699 [Periódico revisado por pares]

Avenel, NJ: Nature Publishing Group

Texto completo disponível

Citações Citado por
4
Peptide vaccination elicits leukemia-associated antigen-specific cytotoxic CD8 T-cell responses in patients with chronic lymphocytic leukemia
Peptide vaccination elicits leukemia-associated antigen-specific cytotoxic CD8 T-cell responses in patients with chronic lymphocytic leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Peptide vaccination elicits leukemia-associated antigen-specific cytotoxic CD8 T-cell responses in patients with chronic lymphocytic leukemia

GIANNOPOULOS, K ; DMOSZYNSKA, A ; SCHMITT, M ; KOWAL, M ; ROLINSKI, J ; GOSTICK, E ; PRICE, D. A ; GREINER, J ; ROJEWSKI, M ; STILGENBAUER, S ; DÖHNER, H

Leukemia, 2010-04, Vol.24 (4), p.798-805 [Periódico revisado por pares]

Avenel, NJ: Nature Publishing Group

Texto completo disponível

Citações Citado por
5
Alemtuzumab (Campath-1H) for treatment of lymphoid malignancies in the age of nonmyeloablative conditioning?
Alemtuzumab (Campath-1H) for treatment of lymphoid malignancies in the age of nonmyeloablative conditioning?
Material Type:
Artigo 		Adicionar ao Meu Espaço

Alemtuzumab (Campath-1H) for treatment of lymphoid malignancies in the age of nonmyeloablative conditioning?

HALE, G ; SLAVIN, S ; GOLDMAN, J. M ; MACKINNON, S ; GIRALT, S ; WALDMANN, H

Bone marrow transplantation (Basingstoke), 2002-12, Vol.30 (12), p.797-804 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
6
Autologous graft-versus-host disease: harnessing anti-tumor immunity through impaired self-tolerance
Autologous graft-versus-host disease: harnessing anti-tumor immunity through impaired self-tolerance
Material Type:
Artigo 		Adicionar ao Meu Espaço

Autologous graft-versus-host disease: harnessing anti-tumor immunity through impaired self-tolerance

KLINE, J ; SUBBIAH, S ; LAZARUS, H. M ; VAN BESIEN, K

Bone marrow transplantation (Basingstoke), 2008-03, Vol.41 (6), p.505-513 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
7
Cancer stem cells: relevance to SCT
Cancer stem cells: relevance to SCT
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cancer stem cells: relevance to SCT

LIN, T ; JONES, R. J ; MATSUI, W

Bone marrow transplantation (Basingstoke), 2009-04, Vol.43 (7), p.517-523 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
8
Factors affecting progression-free survival in hormone-dependent metastatic breast cancer patients receiving high-dose chemotherapy and hematopoietic progenitor cell transplantation: role of maintenance endocrine therapy
Factors affecting progression-free survival in hormone-dependent metastatic breast cancer patients receiving high-dose chemotherapy and hematopoietic progenitor cell transplantation: role of maintenance endocrine therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Factors affecting progression-free survival in hormone-dependent metastatic breast cancer patients receiving high-dose chemotherapy and hematopoietic progenitor cell transplantation: role of maintenance endocrine therapy

MONTEMURRO, F ; RONDON, G ; UENO, N. T ; MUNSELL, M ; GAJEWSKI, J. L ; CHAMPLIN, R. E

Bone marrow transplantation (Basingstoke), 2002-05, Vol.29 (10), p.861-866 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
9
Expression of indoleamine 2, 3‐dioxygenase and the recruitment of Foxp3‐expressing regulatory T cells in the development and progression of uterine cervical cancer
Expression of indoleamine 2, 3‐dioxygenase and the recruitment of Foxp3‐expressing regulatory T cells in the development and progression of uterine cervical cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Expression of indoleamine 2, 3‐dioxygenase and the recruitment of Foxp3‐expressing regulatory T cells in the development and progression of uterine cervical cancer

Nakamura, Takafumi ; Shima, Tomoko ; Saeki, Ai ; Hidaka, Takao ; Nakashima, Akitoshi ; Takikawa, Osamu ; Saito, Shigeru

Cancer science, 2007-06, Vol.98 (6), p.874-881 [Periódico revisado por pares]

Melbourne, Australia: Blackwell Publishing Asia

Texto completo disponível

Citações Citado por
10
Regulatory (FOXP3+) T cells as target for immune therapy of cervical intraepithelial neoplasia and cervical cancer
Regulatory (FOXP3+) T cells as target for immune therapy of cervical intraepithelial neoplasia and cervical cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Regulatory (FOXP3+) T cells as target for immune therapy of cervical intraepithelial neoplasia and cervical cancer

Loddenkemper, Christoph ; Hoffmann, Corinna ; Stanke, Jonas ; Nagorsen, Dirk ; Baron, Udo ; Olek, Sven ; Huehn, Jochen ; Ritz, Joerg‐Peter ; Stein, Harald ; Kaufmann, Andreas M. ; Schneider, Achim ; Cichon, Günter

Cancer science, 2009-06, Vol.100 (6), p.1112-1117 [Periódico revisado por pares]

Melbourne, Australia: Blackwell Publishing Asia

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2002  (1)
  2. 2002Até2005  (2)
  3. 2006Até2006  (1)
  4. 2007Até2008  (6)
  5. Após 2008  (11)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.